Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)
Clinical trial NCT03269773 · COMPLETED
Trial details
- NCT number
- NCT03269773
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2019-03-30
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.